… risk of reactivation of chronic hepatitis B (HBV) and C (HCB). … small study, adalimumab and
ustekinumab were effective for … for hepatitis B infection prior to initiating anti-tumor necrosis …

… While larger studies are needed to further explore the safety … suggests it may be an
effective therapeutic option in this … undergoing anti-tumor necrosis factor therapy or DMARDs …

… world setting by means of a retrospective single center study, … In addition to those cases, in
one case with acute hepatitis B [… treated with adalimumab, etanercept or ustekinumab in daily …

… This was a retrospective cohort study of patients with … cause hepatitis B or C reactivation than
anti-tumor necrosis factor-… , a multicentric prospective cohort study involving 63 patients with …

… Safety and effectiveness of ustekinumab and antitumour … viral hepatitis B or C: a
retrospective, multicentre study in a clinical setting. Br J Dermatol. 2013;168:609-616. …

… treatment option for patients with occult or chronic HBV infection … the retrospective multicenter
study in 20 patients with plaque … psoriasis patients with chronic hepatitis B or C [Citation76]. …

… about safety data in patients with hepatitis B virus, hepatitis C virus … Antitumor necrosis
factor-alpha (anti-TNF-α) agents … retrospective study analyzed the effects of ustekinumab in 44 …

… R, Vilarrasa E, Herranz P, et al: Safety and effectiveness of ustekinumab and antitumour …
viral hepatitis B or C: a retrospective, multicentre study in a clinical setting. Br J Dermatol 2013; …

… , ustekinumab). The natural history of HBV and HCV infection differs significantly as well as
the effect … in association with ultraviolet B therapy) can be a possible option in those subjects …

… While anti-Tumor Necrosis Factor (TNF)-alfa drugs should be … Regarding tildrakizumab, a
recent multicenter real-life study … you can manage your cookie settings, please see our Cookie …